Menu
Log In Sign Up
Article

tat ha2 fusion peptide Transducible TAT-HA fusogenic peptide

Published October Oct 17, 2026 7:51 AM

In the specialized field of biochemical research, the pursuit of efficient intracellular delivery systems has led to the development of sophisticated chimeric molecules. Among these, the TAT-HA2 fusion peptide stands out as a bifunctional tool designed to address the persistent challenge of endosomal entrapment. As someone who follows advancements in peptide sc TAT-HA2 Fusion Peptide Cell-Penetrating ience, I have found the structural integration of these two distinct domains to be a fascinating example of biomimetic engineering.

Structural Composition and Functionality

The TAT-HA2 fusion peptide is effectively a chimeric fusion peptide that combines two well-characterized biological motifs. To understand its utility, one must look at the individual components:

1. The TAT Domain: This segment is derived from the transactivator of transcription (TAT) of the human immunodeficiency virus (HIV). As a member of the cell-penetrating peptides (CPPs) family, TAT is known for its polycationic nature (specifically the sequence GRKKRRQRRRPQ), which facilitates the initial interaction with the cell surface and promotes cellular internalization via lipid raft macropinocytosis.

2. The HA A HA2-Fusion Tag Limits the Endosomal Release of its - PMC 2 Domain: This is a pH-sensitive, fusogenic peptide derived from the Influenza A virus hemagglutinin protein (specifically amino acids 1 to 20). Unlike simple CPPs, this component serves a critical role in endosomal escape.

When combined, these two elements create a delivery agent that does more than just enter the cell. The primary limitation of many delivery vectors is that they become trapped within endosomes. The fusog Buy TAT Conjugated Peptides | Life Sciences enic peptide HA2 undergoes a conformational change in the acidic environment of the endosome, effectively destabilizing the membrane and allowing the cargo to reach the cytosol.

Applications in Research Environments

The TAT-HA2 fusion peptide is capable of being used as a large macromolecule drug delivery peptide. In laboratory settings, researchers often investigate its potential to enhance the uptake of complex cargoes, including proteins and nucleic acids. For instance, the TAT-HA2 peptide is promising as a siRNA delivery vector, as it addresses the need to bypass the endocytic pathway that often degrades such sensitive molecules before they can perform their intended function.

It is worth noting that when fused to Tat peptide, HA2 can enhance endosomal escape of co-treated cargoes significantly. This is supported by the foundational work on the transducible TAT-HA fusogenic peptide, which has been shown to markedly improve the cytosolic delivery of various TAT-fusion proteins.

Technical Considerations for Handling

When sourcing or working with this compound, it is important to verify the purity and the specific sequence. The peptide composed of amino acids 1 to 20 of influenza A virus hemagglutinin protein (HA2) must TAT-HA2 is a chimeric fusion peptide that combines two key functions. It includes the cell-penetrating ability of the HIV TAT sequence and the pH-sensitive,  be correctly synthesized and linked to the TAT sequence to ensure the chimeric nature remains intact.

- CAS TAT-HA2 Fusion Peptide-HongTide Biotechnology Number: 923954-79-4

- Classification: Bifunctional, chimeric cell-penetrating peptide.

- Mechanism: Dual-action; TAT facilita TAT-HA2 Fusion Peptide | Influenza Virus | 923954-79-4 tes entry, while HA2 facilitates endosomal release.

From my observation of the field, the success of this molecu Transducible TAT-HA fusogenic peptide enhances escape of le depends heavily on the nature of the attachment between the two domains. The fusogenic dTAT-HA2 peptide is a specific iteration that has garnered significant attention in literature for its efficiency in overcoming the barriers presented by the endosomal membrane.

Final Reflections

The TAT-HA2 fusion peptide represents a significant milestone in the study of delivery agents. By utilizing a hemagglutinin HA2 peptide to solve the problem of intracellular entrapment, researchers have gained a powerful tool for exploring cellular processes. While TAT peptides are a subset of cell-penetrating pept TAT-HA2 Fusion Peptide | CAS NO.:923954-79-4 ides that have been studied for decades, the addition of the fusion component clearly elevates the performance of this specific construct.

For those interested in the evolution of these tools, the comparison between standard TAT (48-59) amide and the more complex TAT-HA2 demonstrates how modular design—combining a transport motif with a functional release motif—is the current gold standard for high-efficiency intracellular research. As the industry continues to refine these sequences, we can expect to see even more refined iterations of this peptide-based technology.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.